OncoNano Medicine

Dallas, TX · Founded 2014 · Privately Held (backing)

Developer of a nanotechnology platform designed to improve the delivery and activation of cancer therapies in acidic tumor environments. OncoNano Medicine is based in Dallas, TX and was founded in 2014. It was valued at $60 million at its later-stage round in Jun 2025, the last priced event on record. It has raised $117 million across 3 recorded rounds; the latest was a $12.7 million early-stage round in Apr 2025.

PMV mark · valuation
$60.0M
Oct 2026
Priced at
its later-stage round
Jun 2025
Total raised
$116.5M
Last round
Early Stage VC
Apr 2025
What is OncoNano Medicine worth?
$60.0MPrivateMarketView mark · Oct 2026

Valued at $60.0M at its later-stage round, Jun 2025. Nothing has traded since.

Free account
More of OncoNano Medicine with a free account
  • ·Watch OncoNano Medicine: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

OncoNano Medicine funding history

3 rounds
DateRoundRaisedPost-money
Apr 2025Early Stage VC$12.7M▮
Oct 2020Later Stage VC$68.4M▮
Mar 2018Early Stage VC$33.9M▮
Unlock post-money valuations

Membership and data by Private Market View

OncoNano Medicine valuation

OncoNano Medicine was valued at $60 million at its later-stage round in Jun 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has OncoNano Medicine raised?

OncoNano Medicine has raised $117 million across 3 recorded rounds since 2018. The largest was a $68.4 million later-stage round in Oct 2020; the most recent was a $12.7 million early-stage round in Apr 2025.

OncoNano Medicine has filed 7 Form Ds with the SEC since 2018, most recently in Jun 2025 ($12.7 million sold to 25 investors).

How OncoNano Medicine's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For OncoNano Medicine, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about OncoNano Medicine

What is OncoNano Medicine worth?
OncoNano Medicine is valued at $60.0M as of Oct 2026. Valued at $60.0M at its later-stage round, Jun 2025. Nothing has traded since.
How much has OncoNano Medicine raised?
OncoNano Medicine has raised $116.5M in total funding across 3 recorded rounds.
When did OncoNano Medicine last raise?
OncoNano Medicine last raised in Apr 2025 (Early Stage VC), raising $12.7M.